News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,026 Results
Type
Article (1920)
Company Profile (2)
Press Release (67104)
Section
Business (21543)
Career Advice (9)
Deals (4571)
Drug Development (8160)
FDA (1810)
Job Trends (800)
News (37118)
Policy (3565)
Tag
Academia (91)
Alliances (8092)
Alzheimer's disease (114)
Approvals (1815)
Artificial intelligence (6)
Bankruptcy (8)
Best Places to Work (579)
Biosimilars (10)
Biotechnology (5)
Breast cancer (10)
Cancer (107)
Career advice (9)
Cell therapy (11)
Clinical research (6864)
Collaboration (38)
Compensation (5)
COVID-19 (177)
C-suite (6)
Data (105)
Diabetes (9)
Diagnostics (585)
Drug discovery (7)
Duchenne muscular dystrophy (6)
Earnings (7531)
Events (6842)
Executive appointments (23)
FDA (1874)
Funding (27)
Gene therapy (8)
GLP-1 (36)
Government (233)
Healthcare (1131)
Infectious disease (180)
Inflammatory bowel disease (13)
IPO (1619)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (944)
Liver cancer (14)
Lung cancer (18)
Lymphoma (4)
Manufacturing (13)
Medical device (1109)
Medtech (1110)
Mergers & acquisitions (2989)
Metabolic disorders (24)
Neuroscience (137)
NextGen Class of 2024 (218)
Non-profit (61)
Northern California (91)
Obesity (9)
Pancreatic cancer (4)
Parkinson's disease (8)
Patents (9)
People (4929)
Phase I (1860)
Phase II (2863)
Phase III (2614)
Pipeline (47)
Postmarket research (241)
Preclinical (649)
Radiopharmaceuticals (21)
Rare diseases (14)
Real estate (598)
Regulatory (2518)
Reports (6)
Research institute (91)
Schizophrenia (4)
Series A (7)
Southern California (74)
Startups (421)
United States (730)
Vaccines (16)
Date
Today (12)
Last 7 days (68)
Last 30 days (305)
Last 365 days (3338)
2024 (3011)
2023 (3827)
2022 (7022)
2021 (6394)
2020 (5892)
2019 (3869)
2018 (3010)
2017 (3581)
2016 (3191)
2015 (4047)
2014 (3032)
2013 (2627)
2012 (2784)
2011 (2909)
2010 (2664)
Location
Africa (79)
Arizona (5)
Asia (21204)
Australia (2412)
California (187)
Canada (151)
China (77)
Connecticut (7)
Europe (12230)
Florida (15)
Illinois (10)
Japan (29)
Kansas (5)
Maryland (57)
Massachusetts (140)
Minnesota (19)
New Jersey (87)
New York (77)
North Carolina (45)
Northern California (91)
Pennsylvania (30)
South America (105)
Southern California (74)
Texas (10)
Utah (6)
Virginia (8)
69,026 Results for "inspiremd ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, announced the completion of the full exercise of 12.9 million Series H warrants.
July 1, 2024
·
6 min read
Press Releases
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 8, 2024
November 11, 2024
·
5 min read
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
InspireMD, Inc. today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
April 3, 2024
·
1 min read
Press Releases
InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th
November 4, 2024
·
3 min read
Business
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System device for the treatment of Carotid Artery Disease and stroke prevention, announced it will report first quarter 2024 financial results on Tuesday, May 14th, before the financial markets open.
May 7, 2024
·
3 min read
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
InspireMD, Inc. today announced the presentation of positive one-year outcomes from its C-GUARDIANS IDE clinical trial of the CGuard™ Carotid Stent System for the treatment of carotid artery stenosis at this year’s Leipzig Interventional Course (LINC) 2024, which is being held May 28-31, in Leipzig, Germany.
May 28, 2024
·
8 min read
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System
InspireMD, Inc. today announced that the Company has appointed principal investigators (PIs) for its upcoming C-GUARDIANS II clinical trial of the SwitchGuard™ Neuroprotection System (NPS).
February 12, 2024
·
6 min read
Press Releases
InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment
August 5, 2024
·
6 min read
InspireMD to Participate in Upcoming November Investor Conferences
InspireMD, Inc. today announced that the Marvin Slosman, Chief Executive Officer, will participate in three upcoming investor conferences in November.
November 2, 2023
·
1 min read
Business
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the treatment of carotid artery disease and prevention of stroke, announced financial and operating results for the fourth quarter and full-year ended December 31, 2023.
March 6, 2024
·
15 min read
1 of 6,903
Next
